Recombinant protein production downstream defines yield, purity, and GMP readiness. Explore key purification bottlenecks, scale-up risks, and smarter ways to improve recovery and process control.

A compliance risk assessment report should reveal control gaps, data integrity risks, and traceability issues before an audit—see what to review to stay audit-ready.

Pharmaceutical quality systems consultant selection starts with more than SOP review. Learn how to assess GMP readiness, data integrity, validation depth, and real operational fit.